Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 99 INDUSTRY 9 OTHER_GOV 1 NIH 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 1 Hematologic Diseases 1 Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Cyclophosphamide 13 Bevacizumab 9 Interleukin-2 8 aldesleukin 7 Paclitaxel 7 fludarabine phosphate 6 fludarabine 6 Radiotherapy 6 Bortezomib 6 Thalidomide 5 Gemcitabine 5 Filgrastim 5 veliparib 4 sargramostim 4 Vincristine 4 Trastuzumab 4 Prednisone 4 Leucovorin 4 Doxorubicin 4 Biopsy 4 vandetanib 3 tariquidar 3 romidepsin 3 pazopanib 3 montanide ISA 51 3 Topotecan 3 Specimen Handling 3 Sorafenib 3 Sirolimus 3 Oxaliplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Neoplasms × Blood Specimen Collection × Clear all

NCT00166647 2013-01-11

Thiopurine Methyltransferase Polymorphisms Evaluation

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Hematologic Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡